Recent advances in the engineering of nanosized active pharmaceutical ingredients: Promises and challenges

Advances in Colloid and Interface Science
Waseem Kaialy, Maen Al Shafiee

Abstract

The advances in the field of nanotechnology have revolutionized the field of delivery of poorly soluble active pharmaceutical ingredients (APIs). Nanosized formulations have been extensively investigated to achieve a rapid dissolution and therefore pharmacokinetic properties similar to those observed in solutions. The present review outlines the recent advances, promises and challenges of the engineering nanosized APIs. The principles, merits, demerits and applications of the current 'bottom-up' and 'top-down' technologies by which the state of the art nanosized APIs can be produced were described. Although the number of research reports on the nanoparticle engineering topic has been growing in the last decade, the challenge is to take numerous research outcomes and convert them into strategies for the development of marketable products.

References

Oct 1, 1994·Atherosclerosis·A MunozP Reginault
Aug 5, 1998·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Y KawashimaT Niwa
Feb 11, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·C Schmidt, R Bodmeier
Nov 5, 1999·Pharmaceutical Science & Technology Today·P York
Mar 4, 2000·International Journal of Pharmaceutics·C JacobsR H Müller
Nov 25, 2000·Pharmaceutical Science & Technology Today·I WildingA Connor
May 5, 2001·International Journal of Pharmaceutics·G J VergoteJ P Remon
May 17, 2001·Antimicrobial Agents and Chemotherapy·N SchölerO Liesenfeld
Sep 29, 2001·International Journal of Pharmaceutics·P Chattopadhyay, R B Gupta
Feb 19, 2002·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Jichao KangRaymond J Hohl
Mar 2, 2002·Science·I G LoscertalesA M Gañán-Calvo
Apr 17, 2002·International Journal of Pharmaceutics·R H Müller, C Jacobs
Aug 30, 2002·Proceedings of the National Academy of Sciences of the United States of America·N TsapisD A Edwards
Dec 7, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Woo-kyoung LeeJong-sang Park
Feb 21, 2003·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Elaine Merisko-LiversidgeEugene R Cooper
Mar 5, 2003·International Journal of Pharmaceutics·O KayserS L Croft
Mar 12, 2003·Advanced Drug Delivery Reviews·Jayanth Panyam, Vinod Labhasetwar
May 20, 2003·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Hannele EerikäinenP Petri Ahonen
Jul 5, 2003·Advanced Drug Delivery Reviews·Hak Kim Chan, Nora Y K Chew
Sep 5, 2003·International Journal of Pharmaceutics·Hannele Eerikäinen, Esko I Kauppinen
Sep 10, 2003·Journal of Colloid and Interface Science·Ferry IskandarKikuo Okuyama
Dec 31, 2003·International Journal of Pharmaceutics·Jian-Feng ChenHak-Kim Chan
Jan 7, 2004·International Journal of Pharmaceutics·Jeffrey O-H ShamRaimar Löbenberg
Feb 27, 2004·Pharmaceutical Research·Hannele EerikäinenJarno Kansikas
Apr 28, 2004·Drug Development and Industrial Pharmacy·Jiahui HuRobert O Williams
May 26, 2004·International Journal of Pharmaceutics·E B SoutoR H Müller
Sep 2, 2004·Nature Reviews. Drug Discovery·Barrett E Rabinow
Sep 8, 2004·Advanced Drug Delivery Reviews·Lisa Brannon-Peppas, James O Blanchette
Sep 29, 2004·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Jan MöschwitzerRainer H Müller
Oct 23, 2004·Pharmaceutical Research·Elaine Merisko-LiversidgeGary G Liversidge
Jan 18, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hiromitsu YamamotoYoshiaki Kawashima
May 17, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Ana GrenhaCarmen Remuñán-López
Sep 1, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Cornelia M Keck, Rainer H Müller
Sep 10, 2005·American Journal of Respiratory and Critical Care Medicine·Svetlana GelperinaLeonid Heifets
Sep 13, 2005·International Journal of Antimicrobial Agents·Zahoor AhmadG K Khuller
Nov 1, 2005·Tuberculosis·Rajesh PandeyG K Khuller
Jan 18, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jun-ichi JinnoToshikiro Kimura
Jan 26, 2006·European Journal of Pharmacology·Ulrich PisonDavid A Groneberg

❮ Previous
Next ❯

Citations

May 11, 2016·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Shashi Ravi Suman RudrangiBruce David Alexander
Dec 18, 2016·Micromachines·David F Odetade, Goran T Vladisavljevic
Nov 5, 2019·Frontiers in Bioengineering and Biotechnology·Tommaso CasaliniGiuseppe Perale
Jun 16, 2019·Pharmaceutics·Adrian DobrowolskiMarkus Thommes
Aug 19, 2017·Nanoscale Research Letters·Maria MirFakhar Ud Din
May 5, 2021·Langmuir : the ACS Journal of Surfaces and Colloids·Marta RuanoRamon G Rubio

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Opinion in Solid State & Materials Science
Bo Sun, Yoon Yeo
Trends in Cognitive Sciences
H Johansen-Berg
IEEE Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society
M Papadaki
© 2022 Meta ULC. All rights reserved